Sana Biotechnology (SANA) Accumulated Depreciation (2020 - 2026)

Sana Biotechnology (SANA) has 7 years of Accumulated Depreciation data on file, last reported at $57.1 million in Q1 2026.

• For the quarter ending Q1 2026, Accumulated Depreciation changed 0.33% year-over-year to $57.1 million; the trailing twelve-month figure through Mar 2026 stood at $57.1 million (changed 0.33% YoY), and the FY2025 full-year result was $54.8 million, up 1.09% from the prior year.
• Accumulated Depreciation climbed to $57.1 million in Q1 2026, from $54.8 million in the prior quarter.
• In the past five years, Accumulated Depreciation ranged from a high of $57.3 million in Q1 2025 to a low of $22.4 million in Q1 2022.
• A 5-year average of $44.7 million and a median of $47.3 million in 2023 frame the typical range for Accumulated Depreciation.
• Across the five-year window, Accumulated Depreciation surged 124.24% in 2022 and declined 0.33% in 2026, its largest moves.
• Tracing SANA's Accumulated Depreciation over 5 years: stood at $34.0 million in 2022, then gained by 22.94% to $41.8 million in 2023, then advanced by 29.67% to $54.2 million in 2024, then rose by 1.09% to $54.8 million in 2025, then grew by 4.37% to $57.1 million in 2026.
• Business Quant data shows SANA's Accumulated Depreciation at $57.1 million in Q1 2026, $54.8 million in Q4 2025, and $53.8 million in Q3 2025.